ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 227,813 | 211,371 | 197,122 | 190,574 | 148,332 |
| Cost of Goods | 93,389 | 74,615 | 73,037 | 80,280 | 63,075 |
| Gross Profit | 134,424 | 136,756 | 124,085 | 110,294 | 85,257 |
| Operating Expenses | 98,573 | 123,479 | 97,928 | 114,952 | 105,851 |
| Operating Income | 36,240 | 13,892 | 26,194 | -4,378 | -20,519 |
| Interest Expense | 4,727 | 5,438 | 5,484 | 6,015 | 2,331 |
| Other Income | 2,287 | 2,071 | -723 | -3,369 | -8,648 |
| Pre-tax Income | 33,800 | 10,525 | 19,987 | -13,762 | -31,498 |
| Income Tax | 7,183 | 1,976 | 4,306 | -3,486 | -7,332 |
| Net Income Continuous | 26,617 | 8,549 | 15,681 | -10,276 | -24,166 |
| Net Income | $26,617 | $8,549 | $15,681 | $-10,276 | $-24,166 |
| EPS Basic Total Ops | 1.19 | 0.37 | 0.70 | -0.47 | -1.27 |
| EPS Basic Continuous Ops | 1.33 | 0.43 | 0.80 | -0.55 | -1.25 |
| EPS Diluted Total Ops | 1.13 | 0.36 | 0.69 | -0.45 | -1.27 |
| EPS Diluted Continuous Ops | 1.26 | 0.42 | 0.78 | -0.53 | -1.25 |
| EPS Diluted Before Non-Recurring Items | 1.64 | 1.38 | 1.37 | 1.35 | 1.04 |
| EBITDA(a) | $58,872 | $37,173 | $49,085 | $28,597 | $-1,547 |